Table 1. Parameters obtained from... | Rockefeller University Press

Table 1.

Parameters obtained from biochemical assays

	Raw values at pCa 8	Raw values at pCa 4	pCa₅₀ (95% CI)	Hill slope (95% CI)
STF SRX (Fig. 4 a)	15 ± 5%	3 ± 2%	5.5 (5.4–5.7)	2.4 (1.4–2.5)
S1 SRX (Fig. 4 a)	13 ± 2%	12 ± 3%	N/A	N/A
STF ATPase (Fig. 4 a)	0.03 ± 0.01 s⁻¹	0.09 ± 0.02 s⁻¹	6.1 (6.0–6.1)	1.7 (1.3–2.3)
S1 ATPase (Fig. 4 a)	0.03 ± 0.01 s⁻¹	0.03 ± 0.01 s⁻¹	N/A	N/A
STF SRX (2 mM Mg²⁺; Fig. 4 b)	17 ± 2%	1 ± 2%	5.4 (5.2–5.7)	1.8 (0.9–1.9)
STF SRX (0 mM Mg²⁺; Fig. 4 b)	13 ± 1%	3 ± 2%	5.9 (5.8–6.1)	1.1 (0.8–1.5)
FL-myosin SRX (150 mM KCl; Fig. 4 b)	5 ± 3%	4 ± 2%	N/A	N/A
STF ATPase (Fig. 4 c)	0.03 ± 0.01 s⁻¹	0.1 ± 0.02 s⁻¹	6.0 (5.9–6.1)	1.9 (1.4–3.1)
HMM ATPase (Fig. 4 c)	0.03 ± 0.05 s⁻¹	0.03 ± 0.05 s⁻¹	N/A	N/A
25-hep HMM ATPase (Fig. 4 c)	0.1 ± 0.05 s⁻¹	0.1 ± 0.05 s⁻¹	N/A	N/A
2-hep HMM ATPase (Fig. 4 c)	0.08 ± 0.05 s⁻¹	0.07 ± 0.05 s⁻¹	N/A	N/A
S1 ATPase (Fig. 4 c)	0.03 ± 0.05 s⁻¹	0.03 ± 0.05 s⁻¹	N/A	N/A

	Raw values at pCa 8	Raw values at pCa 4	pCa₅₀ (95% CI)	Hill slope (95% CI)
STF SRX (Fig. 4 a)	15 ± 5%	3 ± 2%	5.5 (5.4–5.7)	2.4 (1.4–2.5)
S1 SRX (Fig. 4 a)	13 ± 2%	12 ± 3%	N/A	N/A
STF ATPase (Fig. 4 a)	0.03 ± 0.01 s⁻¹	0.09 ± 0.02 s⁻¹	6.1 (6.0–6.1)	1.7 (1.3–2.3)
S1 ATPase (Fig. 4 a)	0.03 ± 0.01 s⁻¹	0.03 ± 0.01 s⁻¹	N/A	N/A
STF SRX (2 mM Mg²⁺; Fig. 4 b)	17 ± 2%	1 ± 2%	5.4 (5.2–5.7)	1.8 (0.9–1.9)
STF SRX (0 mM Mg²⁺; Fig. 4 b)	13 ± 1%	3 ± 2%	5.9 (5.8–6.1)	1.1 (0.8–1.5)
FL-myosin SRX (150 mM KCl; Fig. 4 b)	5 ± 3%	4 ± 2%	N/A	N/A
STF ATPase (Fig. 4 c)	0.03 ± 0.01 s⁻¹	0.1 ± 0.02 s⁻¹	6.0 (5.9–6.1)	1.9 (1.4–3.1)
HMM ATPase (Fig. 4 c)	0.03 ± 0.05 s⁻¹	0.03 ± 0.05 s⁻¹	N/A	N/A
25-hep HMM ATPase (Fig. 4 c)	0.1 ± 0.05 s⁻¹	0.1 ± 0.05 s⁻¹	N/A	N/A
2-hep HMM ATPase (Fig. 4 c)	0.08 ± 0.05 s⁻¹	0.07 ± 0.05 s⁻¹	N/A	N/A
S1 ATPase (Fig. 4 c)	0.03 ± 0.05 s⁻¹	0.03 ± 0.05 s⁻¹	N/A	N/A